| A crucial role of β1 integrins for keratinocyte migration in vitro and during cutaneous wound repair R Grose, C Hutter, W Bloch, I Thorey, FM Watt, R Fässler, C Brakebusch, ... Oxford University Press for The Company of Biologists Limited 129 (9), 2303-2315, 2002 | 365 | 2002 |
| Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development K Kwon, C Hutter, Q Sun, I Bilic, C Cobaleda, S Malin, M Busslinger Immunity 28 (6), 751-762, 2008 | 336 | 2008 |
| Epidermal stem cells SM Janes, S Lowell, C Hutter The Journal of Pathology: A Journal of the Pathological Society of Great …, 2002 | 313 | 2002 |
| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 229 | 2017 |
| Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ... Journal of Clinical Oncology 37 (31), 2857-2865, 2019 | 178 | 2019 |
| The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets CM Van Tilburg, E Pfaff, KW Pajtler, KPS Langenberg, P Fiesel, BC Jones, ... Cancer discovery 11 (11), 2764-2779, 2021 | 153 | 2021 |
| Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors S Höflinger, K Kesavan, M Fuxa, C Hutter, B Heavey, F Radtke, ... The Journal of Immunology 173 (6), 3935-3944, 2004 | 128 | 2004 |
| Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden P Peneder, AM Stütz, D Surdez, M Krumbholz, S Semper, M Chicard, ... Nature communications 12 (1), 3230, 2021 | 122 | 2021 |
| Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells C Hutter, M Kauer, I Simonitsch-Klupp, G Jug, R Schwentner, J Leitner, ... Blood, The Journal of the American Society of Hematology 120 (26), 5199-5208, 2012 | 99 | 2012 |
| Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies C Hutter, M Minkov ImmunoTargets and therapy, 81-91, 2016 | 75 | 2016 |
| Dermal fibroblast-derived growth factors restore the ability of β1 integrin-deficient embryonal stem cells to differentiate into keratinocytes C Bagutti, C Hutter, R Chiquet-Ehrismann, R Fässler, FM Watt Developmental Biology 231 (2), 321-333, 2001 | 74 | 2001 |
| The cyclin-dependent kinase inhibitor p21 cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells J Zezula, V Sexl, C Hutter, A Karel, W Schutz, M Freissmuth Journal of Biological Chemistry 272 (47), 29967-29974, 1997 | 63 | 1997 |
| Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis T Gerber, S Taschner-Mandl, L Saloberger-Sindhöringer, N Popitsch, ... The Journal of Molecular Diagnostics 22 (8), 1070-1086, 2020 | 57 | 2020 |
| Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis F Halbritter, M Farlik, R Schwentner, G Jug, N Fortelny, T Schnöller, ... Cancer discovery 9 (10), 1406-1421, 2019 | 48 | 2019 |
| Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature A Heisig, J Sörensen, SY Zimmermann, S Schöning, D Schwabe, ... Oncotarget 9 (31), 22236, 2018 | 43 | 2018 |
| High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein α-subunits or of endothelial NO synthase G MANCUSI, C HUTTER, S BAUMGARTNER-PARZER, K SCHMIDT, ... Biochemical Journal 315 (1), 281-287, 1996 | 41 | 1996 |
| Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH A Kolenová, R Schwentner, G Jug, I Simonitsch-Klupp, C Kornauth, ... Blood Advances 1 (6), 352-356, 2017 | 40 | 2017 |
| Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis R Schwentner, A Kolenová, G Jug, T Schnöller, M Ahlmann, B Meister, ... Pediatric Research 85 (6), 856-864, 2019 | 29 | 2019 |
| Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis SK Eder, R Schwentner, P Ben Soussia, G Abagnale, A Attarbaschi, ... Blood Advances 6 (3), 970-975, 2022 | 27 | 2022 |
| Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation M Thian, B Hoeger, A Kamnev, F Poyer, SK Bal, M Caldera, ... haematologica 105 (10), e448, 2020 | 25 | 2020 |
